Background The burden of herpes zoster (HZ) is significant worldwide, with millions affected
and the incidence rising. Current literature has identified some risk factors for this disease; …

Compared with the general population, older adults with immune senescence and
individuals who are immunocompromised (IC) due to disease or immunosuppressive …

Introduction: Efficacy and safety are key aspects when choosing therapies for patients with
inflammatory bowel diseases (IBD). While several randomized trials and indirect …

Abstract Background and Aims Prevention of vaccine-preventable diseases is important in
the care of patients with inflammatory bowel disease (IBD). Thus, accurate immunization …

Abstract Background and Aim We conducted a nationwide validation study of diagnostic
algorithms to identify cases of inflammatory bowel disease (IBD) within the Korea National …

Recent advances in the treatment of inflammatory bowel disease (IBD) include the use of
immune modifiers and monoclonal antibodies, such as tumor necrosis factor (TNF) alpha …

Abstract Background and Aims The effectiveness and safety of vaccinations can be altered
by immunosuppressive therapies, and perhaps by inflammatory bowel disease (IBD) itself …

Big Data, which are characterized by certain unique traits like volume, velocity and value,
have revolutionized the research of multiple fields including medicine. Big Data in health …

Abstract Background & Aims Patients with inflammatory bowel disease (IBD) may be at
increased risk of some vaccine-preventable diseases. The effectiveness and safety of …

Over the past decades, the treatment of inflammatory bowel diseases (IBD) has become
more targeted, anticipating the use of immune-modifying therapies at an earlier stage. This …